Literature DB >> 12534729

Results of resections for hepatocellular carcinoma in a new hepatobiliary unit.

Hong Gee Sim1, London Lucien P J Ooi.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the fourth commonest cancer in Singapore. Surgical resection offers the only chance of "cure". Resection tends to be difficult in HCC because of late presentation and concomitant liver cirrhosis. Specialized units with higher volume of operations are known to produce better results. The present review aims to evaluate early results with HCC resection and discuss the correlation between various tumour prognostic factors and the outcome.
METHODS: The records of 81 consecutive hepatic resections for HCC in the hepatobiliary unit of the Department of General Surgery at the Singapore General Hospital from 1 January 1996 to 31 December 1998 were retrospectively reviewed.
RESULTS: The mean age of the patients was 56.0 +/- 15.4 years. There were more men (M:F: 72:9) and Chinese patients (75 Chinese patients (92.6%); four Malay patients (4.9%); two Indian patients (2.5%)) affected by the disease. Hepatitis B and C carrier status were present in 67.1% (n = 51) and 3.9% (n = 1) of the patients, respectively. Forty-two patients (53.2%) had underlying liver cirrhosis. Twenty-eight patients (34.6%) underwent major hepatectomy and 53 (65.4%) underwent minor hepatectomies. Perioperative mortality was 4.9% (n = 4). The morbidity rate following hepatic resections was 28.4% (n = 23). The median follow up was 21 months (range: 1-52 months). The median survival was 43 months (95% confidence interval (CI): 34.6-51.4 months) after surgery and median time to recurrence was 9.6 months (range: 2-32 months). Overall survival was 79% and 59% at 1 and 3 years, respectively. Disease-free survival was 59% and 30% at 1 and 3 years, respectively. Advance pathological tumour, nodes, metastases (TNM) stage (III and IV), and presence of adjacent organ involvement were risk factors for early recurrence. Advance pathological TNM stage (III and IV) and blood loss of more than 2 L were poor prognostic factors for overall survival.
CONCLUSION: The results of hepatectomies for HCC in the newly established unit at Singapore General Hospital have been shown to be comparable to other established specialized hepatobiliary units with similar perioperative mortality and morbidity rates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534729     DOI: 10.1046/j.1445-2197.2003.02626.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  5 in total

1.  Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

2.  Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver.

Authors:  Mohamed Abdel-Wahab; Tarek Salah El-Husseiny; Ehab El Hanafy; Mohamed El Shobary; Emad Hamdy
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

Review 3.  Management of hepatocellular carcinoma.

Authors:  Janice N Cormier; K Tyson Thomas; Ravi S Chari; C Wright Pinson
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

Review 4.  Hepatocellular carcinoma: defining the place of surgery in an era of organ shortage.

Authors:  Adam Bartlett; Nigel Heaton
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

5.  Prognostic factors after curative resection hepatocellular carcinoma and the surgeon's role.

Authors:  Dong Do You; Dong Goo Kim; Chang Ho Seo; Ho Joong Choi; Young Kyung Yoo; Yong Gyu Park
Journal:  Ann Surg Treat Res       Date:  2017-10-27       Impact factor: 1.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.